Prucalopride
Chemical compound
Prucalopride, sold under brand names Resolor and Motegrity among others, is a medication acting as a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements. Prucalopride was approved for medical use in the European Union in 2009, in Canada in 2011, and in the United States in December 2018.
Nº Q68484 ★★
Uncommon · Knowledge
Prucalopride
Chemical compound
Prucalopride, sold under brand names Resolor and Motegrity among others, is a medication acting as a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements. Prucalopride was approved for medical use in the European Union in 2009, in Canada in 2011, and in the United States in December 2018.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Prucalopride, sold under brand names Resolor and Motegrity among others, is a medication acting as a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements. Prucalopride was approved for medical use in the European Union in 2009, in Canada in 2011, and in the United States in December 2018.
Text: Wikipédia, CC BY-SA 4.0. · Image: Vaccinationist (Public domain) ·
Related cards
Ivabradine
Medication used for the symptomatic management of stable heart related chest pain and heart failure not fully managed by beta blockers
Nº Q425729 ★★
Risankizumab
Chemical compound
Nº Q25112466 ★★
Tesamorelin
Pharmaceutical drug
Nº Q7705415 ★★★
Naltrexone/bupropion
Medication for treatment of obesity
Nº Q4998036 ★
Flurbiprofen
Chemical compound
Nº Q419890 ★★
Apremilast
Chemical compound
Nº Q2858961 ★